Abstract
Though commonly used in drug discovery, alchemical free energy calculations have not been extensively used to explore issues of drug resistance caused by missense mutations to a drug target. Unlike traditional methods, λ-dynamics (λD) can evaluate multiple modifications within a single simulation, however, perturbations on more than one molecule, e.g., in a ligand and receptor, have not been performed previously. In an approach referred to as Multiple Molecule λ-Dynamics (MMλD), simultaneous ligand and protein perturbations are performed in a single simulation to sample a small series of ligands bound to native and T315I mutant Abl kinases, a protein target in chronic myelogenous leukemia associated with drug resistance. MMλD agreement with conventional λD calculations and experiment is high, with mean unsigned errors of 0.21 and 0.79 kcal/mol, respectively. Protein-ligand mutant specific conformational sampling is also identified. Collectively, this work demonstrates that MMλD is a valuable tool for drug-resistance drug discovery.
Supplementary materials
Title
Supporting Information
Description
This SI document contains a description of the computational details and a table of computed binding free energies.
Actions